Judith James to Recombinant Fusion Proteins
This is a "connection" page, showing publications Judith James has written about Recombinant Fusion Proteins.
Connection Strength
0.276
-
Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ß Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2018 09; 70(9):1470-1480.
Score: 0.144
-
Antigenicity of a recombinant Ro (SS-A) fusion protein. Arthritis Rheum. 1990 Jan; 33(1):102-6.
Score: 0.080
-
Lupus autoantibodies recognize the product of an alternative open reading frame of SmB/B'. Biochem Biophys Res Commun. 2001 Aug 03; 285(5):1206-12.
Score: 0.044
-
Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies. J Biol Chem. 1996 Mar 15; 271(11):6342-8.
Score: 0.008